Biotechnology News

May 10, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference

May 10, 2012

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Medivir AB (OMX: MVIR), a research-based specialty pharmaceutical company focused on infectious diseases, today held their AGM. Election of the board of directors and auditor The annual general...

May 10, 2012

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds).

May 10, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that interim results from an investigator-sponsored phase II clinical trial of ADCETRIS (brentuximab vedotin) in patients with relapsed cutaneous T-cell...

May 10, 2012

KALAMAZOO, Mich.--(BUSINESS WIRE)--Axonia Medical, an early stage company pioneering a revolutionary approach to repair and restore damaged peripheral and central nervous systems, announced today that the company has closed on $2.0 million in...

May 10, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the Bank of America Merrill Lynch 2012 Health Care...

May 10, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended March 31, 2012. Financial and operating highlights include: Revenues –...

May 10, 2012

DUSSELDORF, Germany--(BUSINESS WIRE)--The bioeconomy goes global – agenda for 5th European Forum for Industrial Biotechnology announced.

May 10, 2012

BOSTON--(BUSINESS WIRE)--FDA approval and commercial launch of Sorin Group’s new portfolio of pacing, defibrillation and left ventricular with multiple sizes and features to enable physicians to match their implant preference

May 10, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE:AZN) today announced the publication of data demonstrating that SYMBICORT Inhalation Aerosol 320/9 µg twice daily had a safety profile similar to budesonide pressurized metered-dose inhaler (...

May 10, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, at 10:40 a.m. PT. The conference will...

May 10, 2012

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE Healthcare completes acquisition of Xcellerex, a leading provider of single-use technologies for the production of biopharmaceuticals

May 10, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announced plans to invest in its existing U.S. manufacturing operations at its global headquarters and to build a new manufacturing facility in Vietnam.

May 10, 2012

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics adds ophthalmic expert, Dr. Adrienne Graves, to its Board of Directors. The Company is focused on advancing innovative therapies for the treatment of diabetic eye disease and IBD.

May 10, 2012

NEW YORK--(BUSINESS WIRE)--Tonix Pharmaceuticals Holding Corp. (OTCBB: TNXP) (“TONIX” or the “Company”), a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system (“CNS”), including...

May 10, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today reported financial results for the three months ended March 31, 2012, and provided a business update. “We are delighted...

May 10, 2012

STOCKHOLM--(BUSINESS WIRE)--The new Allenex, as a pure transplantation company, is presenting at Avanza Bank stock market day. ”Now that our new Allenex in its new role as a pure transplantation company has reported its first quarterly operating...

May 10, 2012

EMERYVILLE, Calif. & COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--Omicia has initiated an early access program for its individual genome interpretation product; Leroy Hood and Paul Flicek join Scientific Advisory Board

May 10, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) www.internationalstemcell.com today announced that the Company has...

May 10, 2012

EXTON, Pa.--(BUSINESS WIRE)--Medical oncologists have positive patient treatment experiences with Yervoy and Zelboraf.

May 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas. Harvey J. Berger, M.D., chairman...

May 10, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (Spectrum) and Allos Therapeutics, Inc. (NasdaqGS: ALTH) (Allos) today announced that, on May 9, 2012, each had received from the Federal Trade Commission (FTC) a...

May 10, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the upcoming Bank of America Merrill Lynch 2012...

May 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today final results from its completed Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting...

May 10, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced that Jack Howarth, Vice President of Corporate Affairs, will present at the 15th Annual Bank of America Merrill Lynch Health Care Conference on Thursday, May 17,...

May 10, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will hold its Annual Meeting of Stockholders on Thursday, May 17, 2012 beginning at 9:00 AM Eastern at the InterContinental Harbor Court, 550 Light...

May 10, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) announced today that the Financial Industry Regulatory Authority, Inc., also known as FINRA, has approved RXi Pharmaceuticals’ common stock for trading under the...

May 10, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) today announced that Geert Cauwenbergh, Dr. Med. Sc. has been appointed as the Company’s President and Chief Executive Officer. Dr. Cauwenbergh brings more than...

May 10, 2012

GATWICK, England--(BUSINESS WIRE)--Systagenix wound management trains over 1,000 wound care clinicians in over 400 sites globally on new diagnostic wound test - the world's first for wound care.

May 10, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today the reinforcement of its team management with...

May 9, 2012

ROSEMONT, Ill.--(BUSINESS WIRE)--LifeWatch, the leading wireless cardiac monitoring service provider in the United States has launched a strategic alliance with Perminova, a developer of web-based information systems for cardiology centers, to...

May 9, 2012

OSAKA, Japan--(BUSINESS WIRE)--Nitto Denko Corporation announced that a basic patent regarding the company’s epoch-making antifibrotic therapy has been successfully registered in the USA.

May 9, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. Reports First Quarter 2012 Financial and Operating Results

May 9, 2012

WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that U.S. and EU regulatory authorities have accepted the company’s marketing applications for the review of BG-12 (dimethyl fumarate), an oral therapeutic candidate for...

May 9, 2012

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced new manufacturing and supply agreements with Jubilant...

May 9, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports First Quarter 2012 Earnings Results

May 9, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) today reported financial results for the first quarter ended March 31, 2012. For the first quarter of 2012, total operating expenses were $33.9 million, compared to $38.1...

May 9, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 11th Annual JMP Securities Research Conference on Tuesday...

May 9, 2012

BROOKLINE, Mass.--(BUSINESS WIRE)--The Lown Cardiovascular Research Foundation will present two studies that report long-term rates of revascularization and myocardial infarction (MI) in patients receiving optimal medical therapy (OMT), including...

May 9, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend approval of the investigational agent tofacitinib for the treatment of...

May 9, 2012

SEOUL, Korea--(BUSINESS WIRE)--Hanmi Pharmaceutical licenses diazepam nasal spray technology from SK Biopharmaceuticals for marketing in China and Korea.

May 9, 2012

CINCINNATI--(BUSINESS WIRE)--Counter to reports of a drug shortage, BioRx, a national specialty pharmacy, can immediately serve the needs of patients in need of c1 esterase inhibitor (C1-INH) treatment for hereditary angioedem

May 9, 2012

HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced encouraging results from in vivo animal studies completed at...

May 9, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion announced results from a 6-week open-label study demonstrating that patients can effectively be switched to LATUDA (lurasidone HCl) from other antipsychotic agents.

May 9, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced that data from clinical studies investigating Lymphoseek® and AZD469 were accepted for presentation at several upcoming scientific and medical meetings.

May 9, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the release of its Thermo Scientific Laboratory Consumables Catalog, an interactive, online resource that provides customers...

May 9, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention will tackle the most pressing regulatory issues facing the industry - PDUFA V reauthorization, new biosimilars pathway and drug development.

May 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq: HGSI) today confirmed that GlaxoSmithKline plc (GSK) has announced its intention to commence an unsolicited tender offer to acquire all the outstanding common shares of HGS at...

May 9, 2012

HOUSTON--(BUSINESS WIRE)--$7.1 Million Award to Pulmotect to Develop Lead Immune Stimulant